High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$646K
$646,996
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
APLS
S
Apellis Pharmaceuticals, Inc.
Sullivan Timothy Eugene
• CFO
Sell to Cover
2026-01-22
$223,901
|
||||||
| APLS |
Apellis Pharmaceuticals, Inc.
|
CFO
Sell to Cover
|
2026-01-22 | $223,901 | S | Form 4 |
| APLS |
Apellis Pharmaceuticals, Inc.
|
CFO
Sell to Cover
|
2026-01-20 | $57,241 | S | Form 4 |
| APLS |
Apellis Pharmaceuticals, Inc.
|
CFO
Sell to Cover
|
2026-01-13 | $85,554 | S | Form 4 |
| APLS |
Apellis Pharmaceuticals, Inc.
|
CFO
Other
|
2025-10-21 | $100,300 | M | Form 4 |
| APLS |
Apellis Pharmaceuticals, Inc.
|
CFO
10b5-1 Sell
|
2025-10-21 | $280,300 | S | Form 4 |